Biomedical subjects
J O Alvsaker
Publications and source records attributed to J O Alvsaker.
[Drug therapy in uratic arthritis. II. Prevention of new attacks].
Explore the source record for details and available documents.
[Pharmacotherapy in uratic arthritis. I].
Explore the source record for details and available documents.
Plasma 11-hydroxycorticosteroids in acute myocardial infarction.
Explore the source record for details and available documents.
Plasma concentrations of the urate-binding alpha 1-2 -globulin in patients with different types of primary gout as compared to healthy control subjects.
Explore the source record for details and available documents.
Urate--plasma protein interactions.
Explore the source record for details and available documents.
Presence of ornithine in the urate-binding alpha-alpha2 globulin.
Explore the source record for details and available documents.
Studies on the possible presence of the urate-binding alpha-1-alpha-2 globulin in human erythrocytes.
Explore the source record for details and available documents.
Genetic studies in primary gout. Investigations on the plasma levels of the urate-binding alpha 1-alpha 2-globulin in individuals from two gouty kindreds.
The plasma levels of the urate-binding alpha(1)-alpha(2)-globulin, as determined by its urate-binding capacity, have been recorded in 19 individuals from two gouty kindreds. A significantly reduced binding capacity, accounting for 13-30% of the mean value obtained in healthy, unrelated control subjects, was found in all cases of gout and in the single case of essential hyperuricemia included in the present study. In addition, six apparently healthy members of one of these kindreds also exhibited this characteristic. The distribution of the characteristic in three subsequent generations from this kindred further supported the hypothesis that the reduced binding capacity was inherited as an autosomal trait for which affected subjects were heterozygous. Based on the present observation, the mechanisms of inheritance in primary gout are discussed with special emphasis on the possible cooperation of genetic and environmental factors.
The presence of vitamin A in human tryptophan-rich prealbumin.
Human tryptophan-rich prealbumin has been isolated from serum and its homogeneity evaluated by immunoelectrophoresis and polyacrylamide-gel electrophoresis. The green fluorescence of the protein when exposed to ultraviolet light was shown to be due to the presence of vitamin A. It is suggested that trytophanrich prealbumin represents the hitherto unknown specific transport protein for vitamin A.
[Uric acid gout. Pathogenetic considerations].
Explore the source record for details and available documents.
Presence in lipoproteins from human serum of a crystalline blue fluorescent substance of unknown structure isolated from bovine liver.
Explore the source record for details and available documents.
Uric acid in human plasma. V. Isolation and identification of plasma proteins interacting with urate.
Explore the source record for details and available documents.
Uric acid in human plasma. IV. Investigations on the interactions between urate and the macromolecular fraction in plasma from healthy individuals and patients with diseases associated with hyperuricemia.
Explore the source record for details and available documents.
Uric acid in human plasma. 3. Investigations on the interaction between the urate ion and human albumin.
Explore the source record for details and available documents.